McKesson Corporation vs US Bancorp — how do they compare? McKesson Corporation trades at $832.45 (market cap $97.35B), while US Bancorp trades at $63.14 (market cap $98.36B). The key difference: McKesson Corporation and US Bancorp are close in size by market cap, and US Bancorp pays the higher dividend (3.29%). Which is the better fit depends on your goals.
| MCK | USB | |
|---|---|---|
Market Cap | $97.35B | $98.36B |
Sector | Health | Financials |
52-Week High | $995.69 | $64.01 |
52-Week Low | $659.01 | $43.94 |
Enterprise Value | $101.98B | — |
Dividend Yield | 0.39% | 3.29% |
Trailing returns across standard periods
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →